180 related articles for article (PubMed ID: 31964449)
1. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension.
Pardo A; Kando JC; King TR; Rafla E; Herman BK
CNS Spectr; 2020 Dec; 25(6):774-781. PubMed ID: 31964449
[TBL] [Abstract][Full Text] [Related]
2. Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults.
Herman BK; Bouhajib M; King TR; Kando JC; Pardo A
J Atten Disord; 2021 Apr; 25(6):803-808. PubMed ID: 31027435
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
4. Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole.
Abbas R; Childress AC; Nagraj P; Rolke R; Berry SA; Palumbo DR
Clin Ther; 2018 May; 40(5):733-740. PubMed ID: 29703430
[TBL] [Abstract][Full Text] [Related]
5. An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
Marraffino A; Sikes CR; Laage T; Volosov A; Hart A; Engelking D
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):15-20. PubMed ID: 31295008
[No Abstract] [Full Text] [Related]
6. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Stark JG; Engelking D; McMahen R; Sikes C
Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder.
Childress AC; Chow H
Expert Rev Clin Pharmacol; 2019 Oct; 12(10):965-971. PubMed ID: 31526076
[No Abstract] [Full Text] [Related]
8. Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder.
Childress AC; Kando JC; King TR; Pardo A; Herman BK
J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):2-8. PubMed ID: 30575407
[TBL] [Abstract][Full Text] [Related]
9. A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules.
Pardo A; Bouhajib M; King TR; Rafla E; Kando JC
CNS Spectr; 2022 Jun; 27(3):309-314. PubMed ID: 33267925
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
11. Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD.
Pardo A; King TR; Rafla E; Kando JC
Drug Des Devel Ther; 2021; 15():2979-2985. PubMed ID: 34262263
[TBL] [Abstract][Full Text] [Related]
12. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder.
Cutler AJ; Childress AC; Pardo A; Duhoux S; Gomeni R; Rafla E; King TR; Kando JC
J Clin Psychiatry; 2022 Jul; 83(5):. PubMed ID: 35857716
[No Abstract] [Full Text] [Related]
14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
Yang L; Zhang L; Luo Z
Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect.
Caras S; Sharpe T
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):69-80. PubMed ID: 31809216
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
Wang M; Wang M; Zhang Q; Zong S; Lv C
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
Stark JG; Engelking D; McMahen R; Sikes C
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):216-222. PubMed ID: 27936898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
